Cation exchange chromatography (CEX) is a well established strategy for the characterization of monoclonal antibodies (mAbs). The optimization of mobile phase conditions is well described in the literature, but there is a lack of information about CEX stationary phases for the analysis of therapeutic proteins. The aim of this study was to compare five state-of-the-art CEX stationary phases based on the retention, selectivity and resolving power achieved in pH- and salt-gradient modes, with various therapeutic mAbs and their variants. The Sepax Antibodix WCX-NP3, Thermo MAbPac SCX-10 RS, YMC BioPro SP-F, Waters Protein-Pak Hi Res SP and Agilent Bio mAb NP1.7 SS were considered in this study. In terms of retention, the YMC Bio Pro SP-F materi...
Monoclonal antibodies (mAb) currently dominate the market for protein therapeutics. Because chromato...
The retention behavior of a monoclonal antibody has been characterized on a weak cation exchanger, F...
The purification of a biopharmaceutical is not a simple task, and to ensure the quality and consiste...
Cation exchange chromatography (CEX) is a well established strategy for the characterization of mono...
tCation exchange chromatography (CEX) of therapeutic monoclonal antibodies is generally performedwit...
Cation exchange (CEX) chromatography is widely used for large-scale separation of monoclonal antibod...
Characterization of monoclonal antibodies (mAbs) and related products requires the identification of...
The separation performance of a chromatographic system is often described in terms of column efficie...
Therapeutic monoclonal antibodies (mAbs) represent a very important class of the current biopharmace...
This work demonstrates that the type of ion-exchanger (anion or cation), the mode of operation (bind...
Cation exchange chromatography, as part of the monoclonal antibody purification train, is known as a...
The development of monoclonal antibodies (mAbs) has been one of the hottest areas in the pharmaceuti...
The successful application of monoclonal antibodies (mAb) in oncology and autoimmune diseases paved ...
Ion-exchange chromatography (IEX) is a historical technique widely used for the detailed characteriz...
The goal of this second part was (i) to evaluate the performance of commercially available HIC colum...
Monoclonal antibodies (mAb) currently dominate the market for protein therapeutics. Because chromato...
The retention behavior of a monoclonal antibody has been characterized on a weak cation exchanger, F...
The purification of a biopharmaceutical is not a simple task, and to ensure the quality and consiste...
Cation exchange chromatography (CEX) is a well established strategy for the characterization of mono...
tCation exchange chromatography (CEX) of therapeutic monoclonal antibodies is generally performedwit...
Cation exchange (CEX) chromatography is widely used for large-scale separation of monoclonal antibod...
Characterization of monoclonal antibodies (mAbs) and related products requires the identification of...
The separation performance of a chromatographic system is often described in terms of column efficie...
Therapeutic monoclonal antibodies (mAbs) represent a very important class of the current biopharmace...
This work demonstrates that the type of ion-exchanger (anion or cation), the mode of operation (bind...
Cation exchange chromatography, as part of the monoclonal antibody purification train, is known as a...
The development of monoclonal antibodies (mAbs) has been one of the hottest areas in the pharmaceuti...
The successful application of monoclonal antibodies (mAb) in oncology and autoimmune diseases paved ...
Ion-exchange chromatography (IEX) is a historical technique widely used for the detailed characteriz...
The goal of this second part was (i) to evaluate the performance of commercially available HIC colum...
Monoclonal antibodies (mAb) currently dominate the market for protein therapeutics. Because chromato...
The retention behavior of a monoclonal antibody has been characterized on a weak cation exchanger, F...
The purification of a biopharmaceutical is not a simple task, and to ensure the quality and consiste...